Position Summary

The Global Medical Director for Solid Tumors will have accountability to act as the strategic and operational leader for the integrated global medical strategy for assigned Tumors within the Women's Cancer and Specialty Tumor portfolio under the leadership of the Executive Director Women's Cancers/ Melanoma/ Specialty Tumor Medical Program Lead. The Global Medical Director will develop and drive execution of the corresponding Global Medical Plans ensuring cross functional integration, provide strategic direction for creation of compelling, contextualized, practice informing scientific narratives and be a proactive strategic partner for the broader BMS Commercialization and R&D organizations. This position requires deep scientific expertise, cross-functional leadership and a strong understanding of the evolving oncology landscape

Key Responsibilities

• Drive the development and execution of the global medical strategy for accountable tumors/assets ensuring cross-functional input and Medical Program Lead alignment. Provide strategic direction to global markets that inform local medical plans and support lifecycle management and launch readiness
• Drive strategic cross-functional external engagement and advocacy plans that champion the optimal use of our medicines. Focus and engage with high-impact external influencers/thought leaders, investigators and advocacy groups to foster robust scientific exchange and translate key insights to shape development of BMS pipeline
• Maintain ongoing long-term collaborative peer-to-peer relationships with key global thought leaders and oversight over activities, including advisory boards, congress encounters, symposia speaking engagements and alignment with markets/other cross functional partners to ensure efficient and impactful thought leader collaboration.

• Collaborate with Medical Communication leads for the overall successful delivery of Global Medical Communications plans. Provide scientific guidance to create differentiated and compelling scientific stories and ensure impactful dissemination of key data. Represent BMS at global oncology congresses and forums, elevating the visibility of our medicines and their clinical value. Ensure optimal modalities are leveraged to generate impactful medical communication plans

• Provide medical support for governance meetings, brand meetings, access meetings, tumor CDTs and GPT. Integrate medical perspectives, emerging trends and key scientific insights to inform key strategies and development plans

• Partner with Medical Evidence Generation to develop or refine asset/tumor Integrated Evidence Plans that ensure our evidence generation activities align with the most critical unmet need, strategic objectives while leveraging appropriate modalities

• Cross-collaborate with MPLs and other disease area team members with tumor/asset overlap to advise on development strategy as well as alignment overall with disease area strategy.

• Provide program highlights/updates with Medical Leadership and/or corporate leadership as requested

• Ensure allocated budget and resources are appropriately utilized to plan and consistent with business needs, and in compliance with corporate policies.

• Contribute to broader Global Medical or TA initiatives; identify opportunities for innovation in medical execution, including AI, digital engagement and real-world evidence generation.

Qualifications & Experience

• Life sciences and/or healthcare professional training with an advanced degree is required (MD, PharmD, PhD).
• Minimum of 5-7 years working in the pharmaceutical industry (Medical Affairs/Medical Strategy, Clinical Research).
• The successful candidate should have strong analytical skills, strong scientific data interpretation + contextualization and ability to work effectively with cross functional teams including clinical, commercialization, regulatory, HEOR and Access.
• Excellent strategy development, critical thinking, decision making and demonstrated ability to successfully create and implement both short and long-range plans.
• Entrepreneurial thinking, anticipates needs, assesses and manages business and organizational risks.
• They should be highly organized and motivated and possess excellent people management, interpersonal, and strong communication skills, both verbal and written

#LI-HYBRID

Compensation Overview:

Princeton - NJ - US: $207,490 - $251,433

The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee's work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.

Eligibility for specific benefits listed on our careers site may vary based on the job and location. For more on benefits, please visit https://careers.bms.com/life-at-bms/.

Benefit offerings are subject to the terms and conditions of the applicable plans in effect at the time and may require enrollment. Our benefits include:

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.

Work-life benefits include:

Paid Time Off

• US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
• Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays

Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

*Eligibility Disclosure: The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work. Summer hours are generally not available for field sales and manufacturing operations and may also be limited for the capability centers. Employees in remote-by-design or lab-based roles may be eligible for summer hours, depending on the nature of their work, and should discuss eligibility with their manager. Employees covered under a collective bargaining agreement should consult that document to determine if they are eligible. Contractors, leased workers and other service providers are not eligible to participate in the program.

On-site Protocol

BMS has an occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based and remote-by-design jobs. The occupancy type that you are assigned is determined by the nature and responsibilities of your role:

Site-essential roles require 100% of shifts onsite at your assigned facility. Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a positive Company culture. For field-based and remote-by-design roles the ability to physically travel to visit customers, patients or business partners and to attend meetings on behalf of BMS as directed is an essential job function.

R[redacted] : Director, Global Medical Oncology, Solid Tumor Medical Lead, Women's Cancers & Specialty Tumors